Michael Ackermann
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Ackermann
Earlier roles on record: Board Member at Tarsus Pharmaceuticals, Inc. (TARS) until December 2, 2022. Tarsus Pharmaceuticals, Inc. reported in an 8-K filed December 7, 2022 that Michael Ackermann resigned as member of the Board and any committees of the Board, effective December 2, 2022. Tarsus Pharmaceuticals, Inc. reported in an 8-K filed December 7, 2022 that Michael Ackermann resigned as Chairperson of the Board, effective December 2, 2022.
“On December 1, 2022, Michael Ackermann, the Chairperson of the Board of Directors (the "Board") of Tarsus Pharmaceuticals, Inc. (the "Company") notified the Company of his resignation as the Chairperson and as a member of the Board and any committees of the Board, effective December 2, 2022.”
“On December 1, 2022, Michael Ackermann, the Chairperson of the Board of Directors (the "Board") of Tarsus Pharmaceuticals, Inc. (the "Company") notified the Company of his resignation as the Chairperson and as a member of the Board and any committees of the Board, effective December 2, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Tarsus Pharmaceuticals, Inc. (TARS)
Proxy statement
Start not stated–2022-05-02
Last confirmed by a filing; no departure on record
-
Start not stated–2022-12-02
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.